Our business strategy is to take our development programs through clinical proof-of-concept studies and then to seek partners for commercialization. In certain instances, we will be interested in partnering opportunities earlier in development, and in others, we will complete development and commercialization on our own.

In order to maximize the value and potential of our platform and pipeline, we are receptive to a wide variety of business development opportunities across the development spectrum.